FDA Approved: ALPRAZOLAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Alprazolam from Hikma Pharmaceuticals USA Inc. under ANDA074312, granting regulatory clearance for an updated ve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Panic Disorder

Drugs mentioned

• Alprazolam (alprazolam)

Snippet

SUPPL AP for ALPRAZOLAM (ALPRAZOLAM)